Molecular basis for binding promiscuity of antagonist drugs
- 11 December 1991
- journal article
- editorial
- Published by Elsevier in Biochemical Pharmacology
- Vol. 42, S1-S8
- https://doi.org/10.1016/0006-2952(91)90385-i
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Conformation-activity relationship study of 5-HT3 receptor antagonists and a definition of a model for this receptor siteJournal of Medicinal Chemistry, 1990
- Signal transduction in bacteriaNature, 1990
- Structural basis of β‐adrenergic receptor functionThe FASEB Journal, 1989
- Role of primary and secondary protein structure in neurotransmitter receptor activation mechanismsProtein Engineering, Design and Selection, 1988
- Structure-activity relationships for drugs binding to the agonist and antagonist states of the primary morphine receptorJournal of Medicinal Chemistry, 1988
- Molecular dimensions of the substrate binding site of cytochrome P-448Biochemical Pharmacology, 1986
- Depth of side-chain pocket in the S2 subsite of dipeptidyl peptidase IVBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1985
- Problems in in vitro receptor binding studies and identification and role of serotonin receptor sitesNeuropharmacology, 1984
- The differential loss of [3H]pirenzepine vs [3H](−)Quinuclidinylbenzilate binding to soluble rat brain muscarinic receptors indicates that pirenzepine binds to an allosteric state of the muscarinic receptorBiochemical and Biophysical Research Communications, 1984
- Molecular conformation and biological activity of central nervous system active drugsMedicinal Research Reviews, 1982